Paediatric Endocrinology, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hopsital, Pune, Maharashtra, India.
Paediatrics, Cloudnine Hopsital, Malad, Mumbai, Maharashtra, India.
BMJ Case Rep. 2021 May 13;14(5):e242376. doi: 10.1136/bcr-2021-242376.
Wolcott-Rallison syndrome (WRS), the most common cause of permanent neonatal diabetes mellitus (DM) in consanguineous families, has a poor prognosis, with a mean survival of 5.8 years. Majority of children with WRS succumb to the disease in the first decade of life. We present the long-term follow-up of an 8-year-2-month-old girl with genetically proven WRS who was born to a non-consanguineous parentage. She is on basal bolus regimen of insulin therapy for DM. In addition, she was noted to have features of skeletal dysplasia at 3 years and 3 months of age, which has led to her short stature. Surprisingly, she has had no episodes of hepatitis or liver dysfunction so far, which is frequently seen in children with WRS. To the best of our knowledge, she is the oldest surviving patient with WRS reported in India and South Asia.
沃尔科特-拉利森综合征(Wolcott-Rallison syndrome,WRS)是导致近亲家庭中永久性新生儿糖尿病(Diabetes Mellitus,DM)的最常见原因,预后较差,平均存活时间为 5.8 年。大多数患有 WRS 的儿童在生命的第一个十年内死于该疾病。我们报告了一例经基因证实的 WRS 患儿的长期随访结果,该患儿出生于非近亲家庭。她因糖尿病接受基础-餐时胰岛素治疗。此外,她在 3 岁零 3 个月时出现骨骼发育不良的特征,导致身材矮小。令人惊讶的是,她至今没有出现过肝炎或肝功能异常的情况,而这在患有 WRS 的儿童中很常见。据我们所知,她是印度和南亚报道的患有 WRS 后存活时间最长的患者。